Publications
Chemo Combo Shows Promise for Endometrial Cancer Patients
Conquest - Summer 2010
In a recent small study, patients with advanced or recurrent endometrial cancer showed a response rate of 50% when treated with a chemotherapy combination of gemcitabine and cisplatin.
Jubilee Brown, M.D. (left) and Nicki Webb (right), advanced
practice nurse, celebrate with Melissa Sepulveda, an
endometrial cancer patient who benefited from a clinical trial
using gemcitabine and cisplatin.
Until now, survival rates have been low for this group of patients whose options have been either limited or ineffective chemotherapy and hormonal treatment.
This Phase II study of 20 patients found that the combination of these two chemotherapy drugs currently used to treat other types of cancer limited the disease’s progression, increasing progression-free survival while maintaining tolerable toxicity levels. It is believed that when administered together, gemcitabine helps overcome cell resistance to cisplatin, throwing tumor cells a potent one-two punch.
“These results are encouraging, offering a new direction for our research for women who suffer from advanced disease,” says Jubilee Brown, M.D., associate professor in MD Anderson’s Department of Gynecologic Oncology and the study’s lead author.
Reported in March at a plenary session of the Society of Gynecologic Oncologists’ 41st Annual Meeting on Women’s Cancer.
Conquest - Summer 2010
Features
- Survivorship: the Next Step
- Radiological Physics Center Ensures Strength, Applicability of Clinical Trial Results
- It's All Happening in the Children's Cancer Hospital
- Nurturing Future Cancer Prevention Leaders
- Volunteer Pilots Help Connect Patients With Treatment
- Cancer Survivors' Stories: Reasons to Give
- Baseline PET Scans Becoming More Routine
- Moving Forward: Lisa Richardson
- Signs of Hope: 'Beads of Courage' Helps Children Cope With Cancer Treatment
Frontline
- Chemo Combo Shows Promise for Endometrial Cancer Patients
- The Battle Against Lung Cancer Is On
- Chemoprevention for Colon Cancer
- Busulfan Improves Outcomes for Stem Cell Transplant Patients
- Bladder Cancer Risk Higher for Those Who Eat Well-Done Meat
- Stress Helps Ovarian Cancer Cells Escape
- Blood Count Test Helps Predict Leukemia Treatment Outcomes
- Genes Help Identify Some Glioblastomas
- Tool Measures Severity of Transplant-Related Symptoms
- New Guidance for Decisions on Preventive Breast Surgery
- Also in the News